Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of reproductive medicine

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 18161402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RECOMBINANT HUMAN ERYTHROPOIETIN STIMULATES ANGIOGENESIS AND HEALING OF ISCHEMIC SKIN WOUNDS

  2004cited by this paper
• Circulating angiogenic factors during periovulation and the luteal phase of normal menstrual cycles.

  2004cited by this paper
• Pleiotropic functions of erythropoietin.

  2003cited by this paper
• Cycle dependency of intrauterine vascular endothelial growth factor levels is correlated with decidualization and corpus luteum function.

  2003cited by this paper
• Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle.

  2002cited by this paper
• Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia.

  2002cited by this paper
• Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle.

  2001cited by this paper
• Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1.

  2001cited by this paper
• Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils.

  2001cited by this paper
• Steroids and cytokines in endometrial angiogenesis.

  2001cited by this paper
• Human endometrial angiogenesis.

  2001cited by this paper
• Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia.

  2000cited by this paper
• Ovarian steroids in endometrial angiogenesis.

  2000cited by this paper
• Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis.

  2000cited by this paper
• Expression of Vascular Endothelial Growth Factor Receptors in the Human Endometrium: Modulation During the Menstrual Cycle1

  2000cited by this paper
• Hemodynamic Effects of Recombinant Human Erythropoietin

  1999cited by this paper
• Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production.

  1999cited by this paper
• Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow

  1999cited by this paper
• Estrogen-dependent Production of Erythropoietin in Uterus and Its Implication in Uterine Angiogenesis*

  1998cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Vascular endothelial growth factor expression in cycling human endometrium.

  1996cited by this paper
• Endometrial endothelial cell proliferation during the menstrual cycle.

  1994cited by this paper
• Angiogenesis in the female reproductive system

  1992cited by this paper
• Vascular permeability factor: A unique regulator of blood vessel function

  1991cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper

• Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes

  2025cites this paper
• Serum erythropoietin level is increased during stimulation for IVF but not in OHSS

  2024cites this paper
• Effect of Age and Acute Exercise on Circulating Angioregulatory Factors.

  2020cites this paper
• Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis

  2012cites this paper
• Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes.

  2010cites this paper
• Regenerative medicine: does Erythropoietin have a role?

  2009cites this paper
• Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication

  2008cites this paper